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Previewspluripotent cells, while Tet3 (presumably
in combination with Tet1 or Tet2) may
function to control hydroxylation in differ-
entiated cells. Nonetheless, Koh et al.
leave us with several lingering issues
that need to be addressed before we will
understand how DNA methylation and
DNA hydroxylation are functionally
embedded in the epigenetic and genetic
network control of pluripotency. First of
all, it will be important to precisely deter-
mine the location of 5hmC modifications
in ESCs, as well as the gene specificity
of individual Tet enzymes. Furthermore,
the targeting mechanisms that direct indi-
vidual Tets to specific regions/genes
need to be investigated. Finally, it remains
to be seen how hydroxylation itself modu-
lates gene expression.
Toward these goals, Song et al. (2011)
have recently presented one approach
designed to locate 5hmC modifications
in the genome. Their study suggests that
in adult brain cells, which express Tet3,
5hmC is enriched, relative to 5mC, in in-
tergenic regions and both upstream and
downstream of the transcription start
site (TSS). However, the distribution of122 Cell Stem Cell 8, February 4, 2011 ª2011this mark is likely to be distinct in ESCs
and in actively differentiating cells, given
that Tet1 and Tet2 are the predominant
enzymes expressed in these populations
and, relatively speaking, Tet3 is absent.
Technologies that achieve simulta-
neous detection and location of both
5mC and 5hmC are only beginning to be
developed, but with these new tools the
field may soon see ESC profiles that will
hopefully point to answers for these ques-
tions. ChIP and mass spectrometry
experiments with individual Tet enzymes
in ESCs will provide insight into interact-
ing partners and enzyme binding loca-
tions. RNA-Seq in combination with direct
5hmC mapping techniques (e.g., through
hMeDIP) in ESCs depleted for either of
the Tet enzymes will provide further
answers as to possible mechanistic links.
But as stated by Koh et al. (2011), the rela-
tion between Tet function and DNA
methylation is (apparently more) complex
and not necessarily always promoter
directed. It remains an open question as
to which direct or indirect mechanisms
link the presence and absence of 5hmC
to the control of gene expression. DespiteElsevier Inc.the lengthy list of unresolved questions,
the (re)discovery of the sixth base and
of the regulation of Tet enzymes will
greatly influence our understanding of
epigenetic control in stem cells. The time
for new epigenetic concepts in stem cell
research is on the horizon.
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Recently in Cell, Novershtern et al. (2011) reported a comprehensive transcriptome analysis of human hema-
topoiesis, combined with sophisticated bioinformatics analysis and high-throughput DNA binding data for
multiple transcription factors. The resultingmap of regulatory interactions controlling stem cell differentiation
provides a valuable resource for identification of novel hematopoietic regulators.All stem cells share the properties of self-
renewal and multilineage differentiation,
and understanding how these processes
are controlled is a central question of
developmental biology. The hematopoi-
etic system serves as an excellent model
for delineating the regulatory networks
that control self-renewal and differentia-tion of stem cells owing to its easy isola-
tion andmanipulation and because dysre-
gulation of this system results in severe
diseases including immune deficiency
and leukemia. Hematopoietic stem cells
(HSCs) give rise to at least eight distinct
cell lineages through a process in which
self-renewal potential is lost as HSCsdifferentiate into progressively restricted
multipotent progenitors that ultimately
become restricted to a specific cell fate
(Adolfsson et al., 2005). Multiple tran-
scription factors are known to be required
for development of specific hematopoi-
etic lineages or for self-renewal of HSCs,
and their perturbation through gene
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Previewsdeletion or ectopic expression has al-
lowed their placement into regulatory
networks that control essential decision
points (Orkin and Zon, 2008). While the
analysis of single transcription factors
has been highly informative, such studies
allow us to build relatively small networks
with a limited number of transcription
factor interactions and a few defined
targets. The development of genome
wide approaches, including gene expres-
sion profiling and chromatin immunopre-
cipitation followed by deep-sequencing
(ChiP-seq), has revolutionized the scale
on which regulatory networks and tran-
scription factor targets can be identified.
A new study reported in Cell (Novershtern
et al., 2011) takes advantage of these
approaches, combined with sophisti-
cated bioinformatics analysis, to provide
an unprecedented view into the depth
and breadth of the regulatory networks
controlling human hematopoiesis.
The study by Novershtern et al. (2011) is
centered on the analysis of the gene
expression profiles of 211 human samples
representing 38 distinct hematopoietic
populations. These populations included
mature lymphocytes, monocytes, granu-
locytes, erythroid cells, and megakar-
yocytes and their lineage restricted
and multipotent but non-self-renewing
progenitors aswell as HSCs. The resulting
gene-expression profiles were compared
by multiple clustering methods and re-
vealed a set of 80 distinct profiles, or
modules, some of which were cell-type
specific while others were observed in
multiple populations. Ten modules
showed lineage-specific expression and
contained transcription factors shown
previously to regulate development of
the associated lineage. The remaining
modules were divided between those
with HSC and multipotent progenitor
expression and those that come on later
in development and are reused in multiple
lineages. These expression modules have
the potential to reveal important regula-
tors of human hematopoietic differentia-
tion. For example, there were eight
transcription factors expressed in the
granulocyte plus macrophage module,
but only 2 of these, CEBPA and PU.1,
have been described as regulators in
these cells (Laslo et al., 2008). By associa-
tion, the remaining six transcription
factors may play a role in granulocyte or
macrophage differentiation, although thisremains to be tested directly. Gene-
expression profiling has been done previ-
ously to compare mouse hematopoietic
populations, and the conclusions from
these studies are highly congruent (Cham-
bers et al., 2007). For example, lineage
priming, the low-level activation of
lineage-associated genes in multipotent
progenitors, is a common feature of both
mouse andhumanhematopoietic progen-
itors (Mansson et al., 2007; Yoshida et al.,
2010). In addition, in both mice and
humans, the gene expression profiles of
HSCs and multipotent progenitors are
highly distinct from mature cells, as
different as the expression profiles of
different tissues (Chambers et al., 2007).
While gene expression profiles are
informative and frequently reveal pro-
cesses vital to the function of the cell, an
important question is how these gene
expression modules are established and
maintained. To investigate the regulatory
mechanisms controlling gene expression
modules, Novershtern et al. (2011)
enlisted both an ‘‘expression-based’’
and a ‘‘sequence-based’’ analysis. In the
expression-based analysis, transcription
factors that were expressed in the
modules were analyzed using the
‘‘modules network algorithm’’ to identify
factors that ‘‘explain’’ the expression
profile of the module. They identified 220
transcription factors that were associated
with at least one module, but remarkably,
only 15 of these factors were previously
known to function in hematopoiesis. The
model predicts that when a chosen tran-
scription factor, or set of transcription
factors, is present, the module will be
expressed. When these key regulators
are placed within the hematopoietic tree,
clear points of regulation emerge.
In the sequence-based analysis,
promoters for the genes in a module
were examined for common motifs using
six motif-finding algorithms and a motif-
clustering pipeline. These motifs were
then compared to multiple databases of
known transcription factor binding sites.
Both techniques have limitations. For
example, the expression-based analysis
will fail to identify factors that are not
differentially expressed, whereas the
sequence-based analysismay fail to iden-
tify important motifs if they are rare.
Notably, the concordance between these
approaches was not high, potentially due
to these limitations. The authors pro-Cell Stem Cell 8ceeded to combine the expression-based
and sequence-based analysis results with
known transcription factor interactions to
connect the factors expressed in the
modules to their potential transcription
factor targets. The resulting networks
reveal dense transcriptional circuits in
HSCs, which decline during differentia-
tion, while new but less intricate circuits
emerge. While the networks were quite
crowded, the number of factors involved
in establishing the modules is likely an
underestimate because 66 of the motifs
identified in the sequenced-based anal-
ysis were for unknown binding factors.
The abundance of networks in HSCs is
noteworthy, particularly in light of the
observation that mouse HSCs have
a larger transcriptome than their differen-
tiated progeny (Chambers et al., 2007).
Importantly, Novershtern et al. (2011)
tested their model using multiple high-
throughput approaches. They identified
targets of four transcription factors,
MEIS1, TAL1, PU.1, and IKAROS, in
HSCs using ChiP-seq and found a good
correlation with the targets predicted in
their model, demonstrating self-regula-
tion, feed-forward interactions, and core-
gulation of target genes. Intriguingly, they
also found ‘‘anticipatory’’ regulation, that
is, interactions with target genes that are
not expressed in HSCs but, rather, at later
stage of development. This anticipatory
binding may underlie lineage priming, in
which lineage-associated genes are tran-
scribed a low abundance in progenitors
prior to lineage specification (Akashi,
2005).
All of these approaches taken together
reveal potential regulatory networks that
control hematopoietic differentiation.
However, the real test of the model was
to show that the networks identified are
essential in differentiating cells. To
address this issue, Novershtern et al.
(2011) developed a multiplex bead PCR
assay to confirm the expression profiles
of 33 transcription factors during HSC
differentiation to the erythroid or myleo-
monocytic lineages, and they used this
assay to determine the functionality of
shRNAs against each factor. The selected
set of factors could distinguish the two
lineages both in vivo and in vitro using
progenitors from the adult or cord
blood. Moreover, the requirements for
17 factors were tested in an in vitro differ-
entiation assay using shRNA-mediated, February 4, 2011 ª2011 Elsevier Inc. 123
Cell Stem Cell
Previewsknockdown. Notably, 9 of these factors
affected erythroid development whereas
8 factors affected myeloid development.
More than half of these factors were pre-
dicted to regulate the specific lineage
based on the sequence or expression-
based model. Moreover, two of these
factors, HIF3A and AFF1 (encoding the
AF9 protein), were not previously impli-
cated in erythropoiesis but emerged
from this study based on their expression
profile. The scope of the analysis per-
formed in this study on human hemato-
poietic progenitors provides a rich
resource for identifying regulatory124 Cell Stem Cell 8, February 4, 2011 ª2011networks controlling HSC self-renewal,
differentiation, and lineage determination.REFERENCES
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Combining embryological insight with careful analysis of early stage cardiomyocyte differentiation, Kattman
et al. (2011) in this issue of Cell Stem Cell have defined minimal culture conditions to efficiently produce
cardiomyocytes from hESCs and hiPSCs. The lessons learned are applicable to the derivation of other
organotypic cell types.The promise of stem cell biology as an
inexhaustible source of differentiated cells
for research applications and disease
therapies is predicated on the ability to
efficiently produce organotypic cells.
A complementary body of knowledge
from over a century of experimental
embryology offers many insights into
fundamental mechanisms of differentia-
tion. The two fields have come together
nicely in a paper by Kattman et al. in this
issue, describing the efficient and
controlled differentiation of pluripotent
stem cells (PSCs) into cardiomyocytes
(Kattman et al., 2011). The trick to working
out the protocol was combining the use
of embryological markers with careful
titrations of signals that drive cells along
discrete steps toward terminally differenti-
ated, functional cardiomyocytes. The
novelty resides not in the particular
molecules that were used to drive the
production of cardiomyocytes but, rather,
in theapproach they took toestablish idealconcentrations and exposure windows.
Although embryological development
turned out to be a good guide, significant
differences between PSC lines, even
from the same species, necessitated
devising a systematic approach that relied
on parsing development into discrete
steps and optimizing the use of a small
number of embryological signals in each.
These findings epitomize the extrapola-
tion of experimental embryology to stem
cell biology and reinforce the idea that
embryonicdevelopment holdsmanyclues
for controlled differentiation of stem cells.
The strategy takenbyKattman et al. was
enabled by their characterization of the
VEGF receptor-2 (called Flk-1 or KDR)
and PDGF receptor-a (PDGFRa) together
as enriching cardiogenic mesoderm,
which can form cardiomyocytes, endothe-
lial cells, and smooth muscle, as distinct
from hematopoietic progenitors in the
KDR+, PDGFRa population. Since the
divergent TGFb molecules Nodal andBMP, along with Wnt, induce cardiac
mesoderm in embryos (Mercola et al.,
2010), Kattman et al. optimized the
concentration and duration of Activin (as
a surrogate of Nodal) and BMP treatment
(Figure 1). Strikingly, small differences
in concentrations affect the yield of KDR+,
PDGFRa+ cells dramatically and, conse-
quently, reduce the yield of cardiomy-
coytes. Although anticipated by embryolo-
gists knowledgeable of threshold effects
that subtlegradations inActivin concentra-
tion have on inducing different types of
mesoderm, originally shown in Xenopus
(Green et al., 1992) and later generalized
to the mouse and zebrafish (Freeman and
Gurdon, 2002), the finding is puzzling
from a signal transduction perspective
because it is not clear howa small concen-
tration difference is reflected in qualita-
tively different genomic and develop-
mental responses. Timing was as crucial
as dose, because greatly reduced Activin
and Wnt signaling were subsequently
